Portage Biotech Inc.

13F holders, Q1 2024 (March 31)
24holders
3famous investors
$0.56avg. 13F price*

At the end of Q1 2024, 24 institutions reported holding Portage Biotech Inc. in their 13F filings. The largest holders were Armistice Capital, LLC ($938K), Bison Wealth, LLC ($120K) and PEAK6 Investments LLC ($31K). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Portage Biotech Inc.
CUSIP
G7185A128
Latest filing quarter
Q2 2024

History

Number of 13F holders

0510152025 Q1 2024: 24Q1 2024Q2 2024: 22Q2 2024

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions5$42K
Exits3$29K

Ownership 24 holders

Armistice Capital, LLC 0.03% Reduce -11.2% 1,665,885 $938K
Bison Wealth, LLC 0.02% No change 213,398 $120K
PEAK6 Investments LLC 0.00% Add +7.9% 55,263 $31K
Millennium Management 0.00% New 32,827 $19K
Renaissance Technologies 0.00% Add +50.1% 31,663 $18K
BlackRock Inc. 0.00% Reduce -11.3% 31,273 $18K
Citadel Advisors 0.00% Add +61.9% 22,886 $13K
Ieq Capital, LLC 0.00% Add +48.0% 16,650 $9K
XTX Topco Ltd 0.00% New 15,957 $9K
Brown Brothers Harriman & Co. 0.00% New 14,000 $8K
Beacon Investment Advisory Services, Inc. 0.00% No change 11,395 $6K
Sigma Planning Corp 0.00% New 10,680 $6K
Pathstone Holdings, LLC 0.00% No change 10,100 $6K
UBS Group AG 0.00% Add +3438.0% 3,538 $2K
Morgan Stanley 0.00% Add +25.2% 2,000 $1K
Royal Bank of Canada 0.00% Add +1.4% 1,649 $1K
Wells Fargo & Company 0.00% No change 700 $394
National Bank of Canada 0.00% No change 1,455 $339
Credit Agricole S A 0.00% No change 1,350 $324
Princeton Global Asset Management LLC 0.00% No change 150 $85
Abich Financial Wealth Management LLC 0.00% New 60 $34
Toronto Dominion Bank 0.00% No change 7 $4
Qube Research & Technologies Ltd 0.00% No change 4 $2
Cwm, LLC 0.00% No change 215 $0

"% of holder's portfolio" is PORTAGE BIOTECH INC's weight in each manager's 13F, not the share of Portage Biotech Inc. the manager owns.